Antoine Awad
Nessuna posizione attualmente
Patrimonio netto: 50 789 $ in data 30/06/2024
Storia della carriera di Antoine Awad
Precedenti posizioni note di Antoine Awad
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| SYNLOGIC, INC. | Amministratore Delegato | 18/03/2024 | 30/05/2024 |
| Direttore operativo | 30/07/2020 | 18/03/2024 | |
| Direttore Tecnico/Scientifico/R&S | 01/10/2018 | 30/07/2020 | |
| Corporate Officer/Principal | 01/10/2018 | - | |
| MERRIMACK PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
L.E.A.F. Pharmaceuticals LLC
 L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Corporate Officer/Principal | - | - |
| ABPRO CORPORATION | Direttore operativo | - | - |
Formazione di Antoine Awad
| Boston University | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 6 |
Posizioni
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 5 |
| Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SYNLOGIC, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Abpro Corp.
 Abpro Corp. BiotechnologyHealth Technology Abpro Corp. operates as a biotechnology company which develops antibody therapeutics for severe and life threatening diseases. It focusses on novel antibody constructs for immuno-oncology, ophthalmology, and autoimmunity. The company was founded by Ian Chan and Eugene Y. Chan in 2007 and is headquartered in Woburn, MA. | Health Technology |
Merrimack Pharmaceuticals, Inc.
 Merrimack Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Merrimack Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company. engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. | Health Technology |
L.E.A.F. Pharmaceuticals LLC
L.E.A.F. Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology L.E.A.F. Pharmaceuticals LLC engages in a pharmaceuticals company. It develops and commercializes therapies for cancer, autoimmune, and infectious diseases. The company was founded by Clet Niyikiza and is headquartered in Woburn, MA. | Health Technology |
- Borsa valori
- Insiders
- Antoine Awad
- Esperienza
